J 2017

Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients

MARUSIC, A.P., I. LOCATELLI, A. MRHAR, M. CAPRNDA, L. GASPAR et. al.

Základní údaje

Originální název

Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients

Autoři

MARUSIC, A.P. (705 Slovinsko), I. LOCATELLI (705 Slovinsko), A. MRHAR (705 Slovinsko), M. CAPRNDA (703 Slovensko), L. GASPAR (705 Slovinsko), M. ADAMEK (616 Polsko), Peter KRUŽLIAK (703 Slovensko, garant, domácí) a D. PETROVIC (705 Slovinsko)

Vydání

Clinical and Applied Thrombosis-Hemostasis, Thousand Oaks, Sage Publications Inc. 2017, 1076-0296

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30205 Hematology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.852

Kód RIV

RIV/00216224:14110/17:00099909

Organizační jednotka

Lékařská fakulta

UT WoS

000412901900006

Klíčová slova anglicky

prevention of venous thromboembolism; red blood cells; vitamin K; blood replacement

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2018 15:27, Soňa Böhmová

Anotace

V originále

Deep vein thrombosis (DVT) and pulmonary embolisms (PEs) are common complications after surgical procedures. The influence of prescribed blood products on the occurrence of DVT and PE was evaluated in postsurgical patients in this retrospective case-control study. The records of 286 surgical patients were analyzed: DVT (n = 52), PE (n = 92), and a control group (n = 142). The amounts of prescribed blood, blood products, and vitamin K were reviewed, together with appropriate prescribing of low-molecular-weight heparins. The influence of prescribed blood products on the occurrence of DVT or PE was analyzed using multinomial logistic regression. We demonstrated a significant difference between the test and control groups (P < .05) in relation to receiving packed red blood cells. Treatment with red blood cells was associated with an increased risk of PE but not DVT. Patients who developed PE after surgery were hospitalized for longer (median 10 days) than patients with DVT (median 6 days). There was no difference between the test and control groups concerning treatment with fresh frozen plasma. Inadequate thromboprophylaxis significantly increased the likelihood of DVT. There is a connection between receiving packed red blood cells and occurrence of postoperative PE in surgical patients. Thus, patients receiving red blood cells should be monitored more closely after surgery, as they are more likely to develop PE postoperatively.